Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

15 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Early monocyte response following local ablation in hepatocellular carcinoma.
Kimm MA, Kästle S, Stechele MMR, Öcal E, Richter L, Ümütlü MR, Schinner R, Öcal O, Salvermoser L, Alunni-Fabbroni M, Seidensticker M, Goldberg SN, Ricke J, Wildgruber M. Kimm MA, et al. Among authors: salvermoser l. Front Oncol. 2022 Oct 24;12:959987. doi: 10.3389/fonc.2022.959987. eCollection 2022. Front Oncol. 2022. PMID: 36353535 Free PMC article.
Prediction of Protumorigenic Effects after Image-Guided Radiofrequency Ablation of Hepatocellular Carcinoma Using Biomarkers.
Stechele M, Wildgruber M, Markezana A, Kästle S, Öcal E, Kimm MA, Alunni-Fabbroni M, Paldor M, Haixing L, Salvermoser L, Pech M, Powerski M, Galun E, Ricke J, Goldberg SN. Stechele M, et al. Among authors: salvermoser l. J Vasc Interv Radiol. 2023 Sep;34(9):1528-1537.e1. doi: 10.1016/j.jvir.2022.11.024. Epub 2022 Nov 25. J Vasc Interv Radiol. 2023. PMID: 36442741
Post-therapeutic microRNA-146a in liquid biopsies may determine prognosis in metastatic gastrointestinal cancer patients receiving 90Y-radioembolization.
Hirner-Eppeneder H, Öcal E, Stechele M, Öcal O, Gu S, Kimm MA, Wildgruber M, Salvermoser L, Kazmierczak P, Corradini S, Rudelius M, Piontek G, Pech M, Goldberg SN, Ricke J, Alunni-Fabbroni M. Hirner-Eppeneder H, et al. Among authors: salvermoser l. J Cancer Res Clin Oncol. 2023 Nov;149(14):13017-13026. doi: 10.1007/s00432-023-05185-0. Epub 2023 Jul 19. J Cancer Res Clin Oncol. 2023. PMID: 37466799 Free PMC article.
Circulating miR-21 as a prognostic biomarker in HCC treated by CT-guided high-dose rate brachytherapy.
Stechele M, Link H, Hirner-Eppeneder H, Alunni-Fabbroni M, Wildgruber M, Salvermoser L, Corradini S, Schinner R, Ben Khaled N, Rössler D, Galun E, Goldberg SN, Ricke J, Kazmierczak PM. Stechele M, et al. Among authors: salvermoser l. Radiat Oncol. 2023 Jul 28;18(1):125. doi: 10.1186/s13014-023-02316-2. Radiat Oncol. 2023. PMID: 37507808 Free PMC article.
Hsp70 in Liquid Biopsies-A Tumor-Specific Biomarker for Detection and Response Monitoring in Cancer.
Werner C, Stangl S, Salvermoser L, Schwab M, Shevtsov M, Xanthopoulos A, Wang F, Dezfouli AB, Thölke D, Ostheimer C, Medenwald D, Windberg M, Bache M, Schlapschy M, Skerra A, Multhoff G. Werner C, et al. Among authors: salvermoser l. Cancers (Basel). 2021 Jul 23;13(15):3706. doi: 10.3390/cancers13153706. Cancers (Basel). 2021. PMID: 34359606 Free PMC article.
Immune Modulation in Untreated, Contralateral Hepatic Metastases after Yttrium-90 Radioembolization of Microsatellite Stable Colorectal Cancer.
Öcal E, Alunni-Fabbroni M, Piseddu I, Thaler M, Zacherl MJ, Salvermoser L, Stechele MMR, Burnell LF, Hirner-Eppeneder H, Kimm MA, Rudelius M, Seidensticker M, Wildgruber M, Goldberg SN, Ricke J. Öcal E, et al. Among authors: salvermoser l. J Vasc Interv Radiol. 2024 Dec;35(12):1793-1805.e4. doi: 10.1016/j.jvir.2024.07.010. Epub 2024 Jul 22. J Vasc Interv Radiol. 2024. PMID: 39047935 Free article.
15 results